Showing results (241-250 of 314) with videos related to
Sort By:
Pageof 32
Biorxiv : the Preprint Server for Biology|October 4, 2023
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancerLoretah Chibaya, Christina F Lusi, Kelly D DeMarco, et al.Gut|November 1, 2016
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancerThomas A Mace, Reena Shakya, Jason R Pitarresi, et al.Cellular and Molecular Gastroenterology and Hepatology|March 20, 2018
The Esophageal Organoid System Reveals Functional Interplay Between Notch and Cytokines in Reactive Epithelial ChangesYuta Kasagi, Prasanna M Chandramouleeswaran, Kelly A Whelan, et al.The Journal of Clinical Investigation|November 18, 2014
Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinomaJihun Kim, Cameron Fox, Shouyong Peng, et al.JCO Precision Oncology|July 12, 2021
Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline VariantsAnya Mezina, Neil Philips, Zoe Bogus, et al.Cancer Biology & Therapy|August 6, 2010
SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretomeManoj Kumar Kashyap, H C Harsha, Santosh Renuse, et al.Oncotarget|July 25, 2016
Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagusYoomi Lee, Aleksandra M Urbanska, Yoku Hayakawa, et al.EMBO Molecular Medicine|February 1, 2014
Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injurySabyasachi Bhattacharya, Kanstantsin V Katlinski, Maximilian Reichert, et al.Clinical and Translational Gastroenterology|August 21, 2024
Shifts in Serum Bile Acid Profiles Associated With Barrett's Esophagus and Stages of Progression to Esophageal AdenocarcinomaAarti Kumar, Pranav Gwalani, Prasad G Iyer, et al.Journal of the National Cancer Institute|December 22, 2020
Potential Molecular Targets in the Setting of Chemoradiation for Esophageal MalignanciesSalma K Jabbour, Terence M Williams, Mutlay Sayan, et al.Pageof 32